Within the spectrum subtypes of metastatic breast cancer, hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2-) breast cancer emerges as a prevalent type with a poor prognosis [2]. This evidence concerns the gene NR4A1 and breast cancer.